Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-1-2021

Extracellular vesicles, microRNA and the preimplantation embryo:
non-invasive clues of embryo well-being
David Connor Hawke
Schulich School of Medicine & Dentistry

Andrew John Watson
Schulich School of Medicine & Dentistry

Dean Harvey Betts
Schulich School of Medicine & Dentistry, dean.betts@schulich.uwo.ca

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Hawke, David Connor; Watson, Andrew John; and Betts, Dean Harvey, "Extracellular vesicles, microRNA
and the preimplantation embryo: non-invasive clues of embryo well-being" (2021). Paediatrics
Publications. 811.
https://ir.lib.uwo.ca/paedpub/811

39

RBMO VOLUME 42 ISSUE 1 2021

REVIEW

Extracellular vesicles, microRNA and the
preimplantation embryo: non-invasive clues
of embryo well-being
BIOGRAPHY

David Hawke is currently a PhD candidate in the Department of Physiology and
Pharmacology at Western University, Ontario, Canada, under the supervision of Professor
Dean Betts and Professor Andrew Watson. David is focused on improving embryo
selection for transfer using non-invasive extracellular analytes, including microRNA and
extracellular vesicles.
David Connor Hawke1,2,3,4, Andrew John Watson1,2,3,4,
Dean Harvey Betts1,2,3,4,*

KEY MESSAGE

Extracellular vesicles and microRNA are blastocyst secretory products found within spent media microdroplets
after embryo culture. Blastocysts exhibiting either degeneracy or implantation failure release greater amounts
of vesicles and microRNA into the media. These correlations support their use as non-invasive tools to aid
clinical embryo selection for transfer.
ABSTRACT

Elective single embryo transfer is rapidly becoming the standard of care in assisted reproductive technology for
patients under the age of 35 years with a good prognosis. Clinical pregnancy rates have become increasingly
dependent on the selection of a single viable embryo for transfer, and diagnostic techniques facilitating this
selection continue to develop. Current progress in elucidating the extracellular vesicle and microRNA components
of the embryonic secretome is reviewed, and the potential for these findings to improve clinical embryo selection
discussed. Key results have shown that extracellular vesicles and microRNAs are rapidly detectable constituents of
the embryonic secretome. Evidence suggests that the vesicular population is largely exosomal in nature, secreted
at all stages of preimplantation development and capable of traversing the zona pellucida. Both extracellular vesicle
and microRNA concentrations within the secretome are elevated for blastocysts with diminished developmental
competence, as indicated either by degeneracy or implantation failure, whereas studies have yet to firmly correlate
individual microRNA sequences with pregnancy outcome. These emerging correlations support the viability of
extracellular vesicles and microRNAs as the basis for a new diagnostic test to supplement or replace morphokinetic
assessment.
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INTRODUCTION

A

global shift towards elective
single embryo transfer (eSET)
has taken place among assisted
reproductive technology (ART)
since becoming recommended best
practice for patients under the age of 35
years with a good prognosis (The Practice
Committee of the American Society for
Reproductive Medicine and The Practice
Committee of the Society for Assisted
Reproductive Technology, 2013). In the
USA, the number of eSET ART cycles has
increased from 21.4% in 2013 to 28.5%
in 2014, and has now reached 42.7%
as of 2016 for this age group (Centers
for Disease Control and Prevention,
2015; 2016; 2018). This change reflects
the growing requirement to minimize
the serious health complications
associated with a multiple pregnancy
that adversely affects maternal and fetal
health. Embryo cryopreservation has
been pivotal in supporting widespread
use of eSET by enabling sequential single
embryo transfers in the event of a failed
fresh cycle. Although the incidence of
pregnancy resulting from a fresh IVF
cycle is lower when eSET is used over
a double-embryo transfer, once used
in conjunction with frozen embryo
transfer, eSET cumulative pregnancy
incidence quickly becomes comparable
to those from fresh double transfers
(McLernon et al., 2010). This new reality
has generated intense ongoing discussion
about the current state of embryo
selection practices and has launched
substantial research efforts to improve
this process.
Currently, clinics selecting an embryo
for transfer based on morphometrics
do so according to an assessment
of morphology-based criteria at the
pronuclear, cleavage or blastocyst
stages (Nasiri and Eftekhari-Yazdi,
2015). Features such as timing of first
cleavage, blastomere symmetry, cellular
fragmentation, multinucleation, cell count
and pronuclei definition are assessed to
score each embryo using a predefined
grading scheme (Gardner and Balaban,
2016). Morphological assessment
continues to be universally used, as it is
a rapid, technically simple, non-invasive
and cost-effective technique. Although
some new morphometrics are suggesting
embryo morphology still has more to
offer (Ebner et al., 2016; Gazzo et al.,
2020), this approach has fallen under
scrutiny owing to its modest ability to

predict pregnancy after embryo transfer
(Stecher et al., 2014) and the subjectivity
between embryologists (Baxter Bendus
et al., 2006). The addition of time-lapse
systems has garnered mixed consensus
about their benefit (Adamson et al.,
2016; Kieslinger et al., 2016), and
robust improvements in IVF metrics
over conventional culture methods and
morphometric evaluation have not been
demonstrated (Goodman et al., 2016).
The prevalence of aneuploidy among
preimplantation embryos continues to
be a suspected cause of implantation
failure and miscarriage. Although it
remains an ongoing discussion, mounting
evidence suggests identification of a
euploid embryo for transfer significantly
increases implantation, clinical pregnancy
and live birth rates for patients with a
range of indications, including advanced
maternal age and recurrent miscarriage,
as well as good-prognosis patients
using single-embryo transfer (Rubio
et al., 2019). Preimplantation genetic
testing for aneuploidy (PGT-A) using
blastocyst biopsy and next-generation
sequencing (NGS) has now clearly been
shown to have high predictive potential
for forecasting failure to deliver for
preimplantation embryos diagnosed with
aneuploidy (Tiegs et al., 2020). Removal
of a single blastomere for PGT-A at
the cleavage-stage may decrease the
conceptus’ implantation potential (Scott
et al., 2013; Mastenbroek and Repping,
2014); however, the implications of
blastocyst biopsy are far less substantial
(Cimadomo et al., 2016; Tiegs et al.,
2020). Regardless, this assessment may
still be confounded by the prevalence
of genetic mosaicism leading to false
euploid diagnoses (Baart et al., 2006).
Additionally, for blastocyst-stage
biopsy, the procedure requires a skilled
embryologist with specialized equipment
for laser ablation, which are the main
contributors to the cost and accessibility
of this service. The active development
of non-invasive PGT-A (niPGT-A) has
been promising and is showing high
concordance with conventional methods
without the need for embryo biopsy
(Leaver and Wells, 2020).
Development of non-invasive diagnostics
such as niPGT-A take advantage
of accessible extracellular analytes
within the spent blastocyst culture
media and the blastocyst cavity.
These extracellular sources have been
extensively characterized by proteomics

and metabolomics studies (HernándezVargas et al., 2020) in the search
for correlators with aneuploidy and
impending implantation failure. An
explosion of interest in extracellular
vesicles and microRNA sequences has
been driven by their use as therapeutics
(Christopher et al., 2016) and potential
utility as biomarkers of abnormal cellular
states (Huang, 2017). Advances in
methods for isolation and detection have
now extended this latter consideration
into the realm of assisted reproduction
in the hope of improving optimal
embryo selection for embryo transfer.
This review will cover recent studies
that have characterized the extracellular
vesicle and microRNA fractions of the
preimplantation embryonic secretome. In
this context, we use the term secretome
loosely, referring to all extracellular
components originating from the
preimplantation embryo and not just the
proteinaceous fraction. The aims of this
review are to highlight inter-study trends
and showcase results most capable of
furthering the development of eSET
diagnostics.
Extracellular vesicles
Extracellular vesicles are biological
nanoparticles consisting of a lipid bilayer
that originates from a wide range of host
cells throughout the body. Extracellular
vesicles are now renowned for their
ability to carry significant phenotype
altering cargo such as transcription
factors and microRNAs (Anand
et al., 2019). Encapsulated cargo is
significantly more stable and may be
readily internalized by recipient cells.
Extracellular vesicles are classified
according to their biogenesis; however,
their origins are usually implied only
after characterization of the vesicle's
size and membrane composition.
Secreted vesicles may bud directly from
the plasma membrane (microvesicles,
ectosomes), be released from within
an intracellular precursor called the
multivesicular body (MVB) after fusion
with the cell membrane (exosomes) or
form upon cell death, wherein apoptosis
directs partitioning of residual cytoplasm
to more sizeable apoptotic blebs or
bodies. Exosomes are the smallest
class of extracellular vesicles with a
diameter measuring between 40 and
120 nm (Vlassov et al., 2012), whereas
microvesicles range from 50 nm to
1000 nm and apoptotic bodies vary
greatly, ranging anywhere from 500 nm
to greater than a micron (Andaloussi
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et al., 2013). Exosomal biomarkers
are somewhat uninformative as their
transmembrane protein constituency, a
property routinely used for identification
that relies heavily on the tetraspanins
CD9, CD63 and CD81, is not specific
to exosomal extracellular vesicles. The
ubiquitous presence of the tetraspanins
throughout the cell membrane enables
other extracellular vesicle classes
to also bear these markers, as the
membrane is shared structurally. Residual
exosome trafficking proteins involved
in the formation of the MVB, i.e. ALIX
and TSG101, are often found within
exosomes, yet their presence is not
guaranteed (Lötvall et al., 2014). In the
absence of reliable exosome-exclusive
markers, their presence is often inferred
from a combination of these markers
along with their less than 200 nm size
distribution and, occasionally, observation
of MVBs within their probable host
cells. Apoptotic body composition is
highly variable; however, the expression
of phosphatidyl serine within the outer
leaflet of the vesicle membrane is a
reliable characteristic of these vesicles
and may be used for identification.
Recommendations for addressing these
challenges, including proper isolation
and reporting of extracellular vesicle
populations present within limiting
samples, such as preimplantation embryo
conditioned culture media, are available
and updated periodically (Théry et al.,
2018).

the cow (Mellisho et al., 2017; Qu et al.,
2017; Pavani et al., 2019; Dissanayake
et al., 2020), mouse (Pallinger et al.,
2018; Simon et al., 2020) and pig
(Saadeldin et al., 2014). Extracellular
vesicles are released at all stages of
human preimplantation development,
including cleavage-stage embryos and
zygotes (Vyas et al., 2019). Similarly,
all stages of porcine (Saadeldin
et al., 2014), bovine (Qu et al., 2017;
Dissanayake et al., 2020) and mouse
(Pallinger et al., 2018; Simon et al.,
2020) preimplantation embryos have
confirmed extracellular vesicle release.
In all cases, the identified vesicles
presented the hallmark cupped-shape,
double membrane vesicle appearance
and amplification of select embryonicspecific mRNA sequences (POU5F1 and
NANOG [Giacomini et al., 2017]; Oct4,
Sox2, Klf4, c-Myc and Nanog [Saadeldin
et al., 2014]) from extracellular vesicleenriched media fractions confirmed
the embryonic origin of these vesicles.
The media concentration of these
vesicles is reported in the range of 108
and 1011 nanoparticles/ml (TABLE 1) and
increases as development progresses
towards the blastocyst stage (Giacomini
et al., 2017; Vyas et al., 2019). The
range in concentrations likely arises
owing to the differences between
studies in the number of embryos
cultured per microdroplet, microdroplet
volume, differing embryonic stage and
conditioning time.

The 12 main studies covered in this
section focus on the secretome of
the whole preimplantation embryo;
studies characterizing the secretome
of embryo-derived cell lines were not
included. Aspects of these main studies
pertaining to the capture, identification
and characterization of preimplantation
embryo-derived extracellular vesicles
and their relation to developmental
competence are discussed. These main
studies are presented in TABLE 1, and the
review of their contents is supported by
significant results found elsewhere.

The extracellular vesicles present in
spent culture media from day 3 and
day 5 human embryos were positive
for exosomal markers CD9, CD63 and
ALIX (Giacomini et al., 2017). Similarly,
cleavage (Qu et al., 2017) and morulastage (Dissanayake et al., 2020) bovine
embryo-derived extracellular vesicles are
CD9+ and CD9+/CD81+, respectively.
Generally, these extracellular vesicle
populations consisted of vesicles
within 50–200 nm in diameter and the
extracellular vesicle population being
actively released from preimplantation
embryos throughout early development
was concluded to be largely exosomal
in nature. This is supported by the
observation of membrane localized,
CD9+ MVBs in fixed murine cell
slices from oocyte, cleavage-stage
and morula-stage embryos (Simon
et al., 2020), including blastocyst
trophectodermal cells (Shin et al., 2017)
and within trophoblast cells of bovine
blastocysts (Mellisho et al., 2017). Uptake

Extracellular vesicles in the
preimplantation embryonic secretome
Preimplantation embryo-derived
extracellular vesicles are confirmed as
secretory products in spent culture
media collected during human clinical
studies (Abu-Halima et al., 2017;
Giacomini et al., 2017; Pallinger et al.,
2017; Vyas et al., 2019) in addition to
those involving various animal models:
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of human preimplantation embryoderived extracellular vesicles by primary
human endometrial cells has been
demonstrated, suggesting extracellular
vesicles may be involved in the
conceptus–uterus milieu that facilitates
the initial attachment and growth of the
extraembryonic lineages through the
uterine epithelium (Giacomini et al.,
2017).
Extracellular vesicles and the zona
pellucida
It is now clear that embryonic-derived
exosomes are capable of freely
traversing the zona pellucida. In fact,
the direct observation of exogeneous
fluorescently labelled small vesicle
internalization has revealed this flux is
likely bidirectional (Saadeldin et al.,
2014; Kim et al., 2019). Vyas et al. (2019)
observed extracellular vesicles within
the zona pellucida itself by electron
microscopy (Vyas et al., 2019), which
is corroborated by Simon et al. (2020).
This raises the question whether the
contents of the zona pellucida may
provide sufficient embryo-derived
material to be used as a non-invasive
source of diagnostic information.
Indeed, zona pellucida dissolution
before transfer has no negative effect
on implantation success (Urman et al.,
2002). To the best of our knowledge,
no studies have yet sought to correlate
analytes trapped in the zona pellucida
with embryo competence. Curiously,
Vyas et al. (209) were unable to identify
any extracellular vesicles within the zona
pellucida of MII oocytes, suggesting
that preimplantation embryo exosomal
release may be a fertilization-dependent
phenomenon (Vyas et al., 2019).
The pore size of the bovine zona
pellucida ranges from 150 nm to 220
nm from the oocyte to the morulae
stage with no apparent trend (Vanroose
et al., 2000). Obligingly, the primary
media extracellular vesicle populations
are defined by an approximate 200 nm
cut-off in vesicle size when conditioned
with cleavage-stage embryos (TABLE 1), yet
blastocyst media studies have reported
a second, lesser extracellular vesicle
population, with diameters reaching as
high as 400–500 nm (Abu-Halima et al.,
2017; Giacomini et al., 2017; Vyas et al.,
2019; Simon et al., 2020). Microvesiclesized extracellular vesicles matching this
description of 400–500 nm in diameter
have been detected throughout the
perivitelline space (Vyas et al., 2019). It is
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TABLE 1 STUDIES DESCRIBING THE EXTRACELLULAR VESICLE PRESENCE WITHIN THE PREIMPLANTATION EMBRYONIC
SECRETOME
Reference

Species Isolation
method

Identification Developmen- Sample Extracellumethod
tal stage
origin lar vesicle
diameter,
nm

Nanoparticle
Significance
concentration,
nanoparticle/
ml

(Simon et al.,
2020)

Mouse

UC

TEM, NTA

(Dissanayake
et al., 2020)

Bovine

Centrifugation, filtration, SEC

(Vyas et al.,
2019)

Human

(Battaglia
et al., 2019)

Human

CM, BF,
TE, ZP

20–500 (TEM),
50–310 (NTA)

1.74 × 107

Murine oocyte, morula, blastocyst, expanded blastocyst release
extracellular vesicles; extracellular
vesicles in perivitelline space from
oocyte onwards; extracellular vesicles present in the blastocyst cavity.

Microarray,
C, M, B
NTA, SEM, TEM

CM

50–150 (TEM),
30–300 (NTA)

7.17 × 108 (degenerate) versus
5.68 × 108 (B)

Degenerate embryos left behind
media with greater concentrations
of nanoparticles.

Centrifugation

SEM, TEM, NTA O, Z, C, M, B

TE, ZP,
CM

50–500 (TEM), 7.89 × 108 (B),
100–200 (NTA) 7 × 108 (C)

None

SEM, NTA,
ELISA

B

BF

median: 78.4;
mean: 94.0

(Pavani et al., Bovine
2019)

UC, Optiprep

NTA, TEM,
Western

B

CM

25–250 mean: 2.4 × 1010
134; mode: 97.5
(NTA)

(Pallinger
et al., 2018)

Mouse

None

FC

B

CM

NA

∼1.75 × 106 (annex- Mouse blastocysts release extracelin V+ subpopulular vesicles.
lation)

(Qu et al.,
2017)

Bovine

Centrifuga- TEM, FM
tion, UC, BC

C

CM

60–150

NA

Bovine exosomes increase blastocyst formation when reintroduced
into culture media.

(Pallinger
et al., 2017)

Human

Centrifugation

B, E

CM

NA

∼9 × 105 (pregnant), ∼2.2 × 106
(not pregnant) (PI+
subpopulation)

Human blastocysts leading to
implantation success release significantly less PI+ and extracellular
vesicles than those that led to
implantation failure after transfer.

(Mellisho
et al., 2017)

Bovine

Centrifuga- FC, TEM, NTA
tion, UC, BC

E

CM

median: ∼110;
mode: ∼80

3.9–8.5 × 108

Bovine embryos release extracellular vesicles; culture media of embryos with arrested development
had higher vesicle counts (∼40%)
than parthenogenetic blastocysts.

(Giacomini
et al., 2017)

Human

Centrifugation, UC

TEM, NTA,
Western

C, B

CM

50–200 mean:
75

2.6 × 109 (C),
6.26 × 109 (B)

Human embryos release extracellular vesicles; extracellular vesicle
subpopulation with >200 nm
diameter identified.

(Abu-Halima
et al., 2017)

Human

Centrifugation

NTA, TEM

B

CM

30–120 mode:
∼145 (NTA)

3.8 × 109 (pregnant), 7.35 × 109
(not pregnant)

The extracellular vesicle concentration in positive pregnancy
outcomes culture media was about
50% of that in negative outcome.

(Saadeldin
et al., 2014)

Porcine

Centrifuga- TEM, FM, FC
tion, UC, BC

C, B, E

CM

35–100

NA

Porcine embryos release exosomes
that could be internalized by other
embryos in culture after reintroduction.

M, B, E

TEM, FC

2.46 × 109 (BF)

Extracellular vesicles shown to be
capable of passing zona at zygote,
morula and blastocyst stages; extracellular vesicle subpopulation with
>200 nm diameter identified.
Human blastocyst cavity contains
exosomes that are CD63+ and
CD81+.
Embryo-derived exosomes may
be taken up by other embryos in
culture.

B, blastocyst; BC, bead capture; BF, blastocyst fluid; C, cleavage-stage; CM, culture media; E, expanded; FC, flow cytometry; FM, fluorescence microscopy; M, morula;
NTA, nanoparticle tracking analysis; O, oocyte; PI+, propidium iodide-positive; SEC, size exclusion chromatography; SEM, scanning electron microscopy; TE, trophectoderm; TEM, transmission electron microscopy; UC, ultracentrifugation; Z, zygote; ZP, zona pellucida.

possible that larger extracellular vesicles
are breaching the zona pellucida at the
time of blastocyst hatching, making this
a possible viable strategy to generate
greater amounts of accessible material
for non-invasive assessment. Zona
pellucida damaging procedures, namely
intracytoplasmic sperm injection (ICSI)

and somatic cell nuclear transfer (SCNT),
cannot be ruled out either. Although
the implications of such procedures
on the extracellular vesicle population
remains unclear, Saadeldin et al. (2014)
observed no major increases in various
embryonic mRNA when comparing
porcine SCNT embryos with non-SCNT

controls. Pallinger et al. (2017) detected a
significant portion of extracellular vesicles
by flow cytometry in the spent media of
hatched blastocysts after staining with
either annexin V or propidium iodide. The
size distribution was not reported, yet the
successful detection by conventional flow
cytometry suggests the vesicles were over
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200 nm in diameter and the presence
of externalized phosphatidyl serine along
with DNA cargo points towards apoptotic
bodies (Pallinger et al., 2017).
Presence of extracellular vesicles in
the blastocyst cavity
Extracellular vesicles with exosomal
character have now been reported
within the blastocyst cavity of human
blastocysts (Battaglia et al., 2019), and
mouse blastocyst cavity extracellular
vesicles have also been observed (Simon
et al., 2020). In humans, Battaglia et al.
(2019) estimated the blastocyst cavity
extracellular vesicle concentration to
be about 2.5 × 109 nanoparticles/ml,
a value on par with the typical 108–109
nanoparticles/ml reported for culture
media samples. The primary extracellular
vesicle population diameters were
consistent with exosomes, being no
greater than 175 nm with a median of 75
nm. The exosomal tetraspanin presence
of CD63 and CD81 in these vesicles
was confirmed (Battaglia et al., 2019).
The contents of the blastocyst cavity
may prove a more reliable diagnostic
source than the secretome, as it is
impervious to media changes and is
sheltered from contaminating factors
such as residual maternal cumulus cells.
A blastocyst rupturing strategy wherein
its DNA contents are deliberately
released into the culture media has
improved the concordance of niPGT
(Kuznyetsov et al., 2018; Li et al., 2018;
Jiao et al., 2019), and such a strategy
may be worth investigating to improve
extracellular vesicle detectability. The
blastocyst cavity naturally contracts
to varying degrees repetitively during
expansion and, in some cases, complete
collapse may occur (Sciorio et al.,
2020). With certainty, this collapsing
phenomenon has been correlated
with ongoing clinical pregnancy rate
(Huang et al., 2016; Marcos et al., 2015;
Sciorio et al., 2019; 2020). Only 37.5%
of transferred human blastocysts that
exhibited at least one total collapse
resulted in pregnancy, compared with
51.9% resulting from those with minor
or no collapse (Sciorio et al., 2020).
The ejection of these contents at a time
when the zona pellucida has thinned or
ruptured lends plausibility to the notion
that such a release mechanism could be
a major blastocyst-specific mechanism
expediting release of extracellular
vesicles and other analytes, such as
microRNAs into the spent culture
media.

Extracellular vesicle isolation and
analysis
An overnight or 24-h period seems
to be sufficient to condition medium
sufficiently for reliable detection. In each
study in TABLE 1, culture media samples
were frozen at –80°C before extracellular
vesicle isolation and characterization.
Freeze–thaw cycles can diminish total
extracellular vesicle yield by as much as
50% per cycle (Cheng et al., 2019), and
it is likely the sensitivity of extracellular
vesicles detection in conditioned media
sample may be improved substantially
by analysing fresh samples. The toolkit
available to investigators looking to
isolate a scarce vesicle population
from small volumes of starting material
is limited and depends highly on the
requirements of the downstream
analysis; common isolation techniques,
such as ultrafiltration and size exclusion
chromatography, are generally not
compatible with single embryo culture
media samples. The bovine has proven
instrumental in this regard as high
numbers of oocytes may be fertilized and
cultured in a single experiment to bolster
biomaterial availability within conditioned
media (Kropp et al., 2014; Kropp and
Khatib, 2015; Gross et al., 2017; Mellisho
et al., 2017; Qu et al., 2017; Pavani et al.,
2019; Dissanayake et al., 2020).
Of the 12 papers listed in TABLE 1,
extracellular vesicle isolation was
conducted by numerous means: eight
used differential centrifugation, six
used ultracentrifugation, three used
bead capture, one used size exclusion
chromatography, one used filtration and
two proceeded to analyse crude media
(non-summative). The choice of vesicle
purification method is a factor that
significantly affects the interpretation
of the resulting extracellular vesicle
population (Brennan et al., 2020).
Differential centrifugation is used to
remove larger cell debris, such as
apoptotic bodies, and is often used in
tandem with ultracentrifugation to purify
and isolate the exosomal fraction. This
purification regimen can be repeated
multiple times to increase the purity
of the isolate and is adequate for
subsequent vesicle analysis by electron
microscopy. Bead capture was used
successfully when vesicles needed to
be clustered to meet the minimum
threshold for detection by fluorescence
microscopy and flow cytometry. Size
exclusion chromatography enables
vesicle ‘washing’ to remove salts and
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other contaminants that may confound
downstream analysis. Even the smallest
commercial columns, however,
produce elution fractions that are a
greater volume than embryo culture
microdroplets limiting its use in this
application to large volumes of pooled
media (Dissanayake et al., 2020).
Material losses make these approaches
inappropriate for media samples that
have been conditioned by a single
embryo. When it comes to single embryo
resolution, currently crude media works
best when paired with compatible
analytics (Abu-Halima et al., 2017;
Pallinger et al., 2017).
In the 12 extracellular vesicle papers
in TABLE 1, extracellular vesicles were
analysed by the following methods: 10
used transmission electron microscopy
(TEM), seven used nanoparticle tracking
analysis (NTA), four used flow cytometry,
three used scanning electron microscopy,
and two used fluorescence microscopy
(non-summative). Media conditioned with
a single day-5 human blastocyst must
be analysed ‘on-the-fly’ within a matter
of hours to be used as a diagnostic for
embryo selection from a fresh cycle.
Electron microscopy remains the gold
standard for characterizing individual
extracellular vesicles by enabling
visualization of morphological features,
such as the bilipid membrane in tandem
with immunolabelling for markers
such as tetraspanins. Embryo-derived
extracellular vesicles may be visualized
by fluorescence microscopy; however,
both groups that used this method used
aldehyde/sulfate bead capture to first
concentrate extracellular vesicles from
the media (Saadeldin et al., 2014; Qu
et al., 2017). In a clinical setting, these
microscopic methods are unable to
easily resolve population level ‘macro
characteristics’, such as size distribution
or total number of extracellular vesicles.
Traditional Western blotting of exosomal
fractions from embryo conditioned media
has been demonstrated (Giacomini et al.,
2017; Pavani et al., 2019); however, the
biomass requirements call for substantial
starting media volumes that are simply
not clinically feasible. Nanoparticle
tracking analysis allows nanoparticles to
be rapidly observed in suspension with
minimal upstream sample purification.
It has a minimum nanoparticle
concentration requirement of about
106 nanoparticles/ml in a 1-ml loaded
sample, an acceptable limitation for this
application. It is capable of fully resolving
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the nanoparticle population within
pooled embryo culture media samples
(Giacomini et al., 2017; Battaglia et al.,
2019; Pavani et al., 2019; Vyas et al.,
2019; Simon et al., 2020). In fact, the
technique effectively characterized single
microdroplets conditioned with a small
cohort of six embryos (Giacomini et al.,
2017) and even single embryo resolution
has been achieved after conditioning with
both cleavage-stage and blastocyst-stage
embryos with varying degrees of success
(Abu-Halima et al., 2017; Mellisho et al.,
2017; Dissanayake et al., 2020). Of these
single embryo studies, Abu-Halima et al.
(2017) had no background contaminants
in their unconditioned culture media;
however, both Mellisho et al. (2017) and
Dissanayake et al. (2020) encountered
difficulties reliably differentiating between
embryo-derived extracellular vesicles and
the pre-existing nanoparticle populations
within the commercial media before
embryo exposure. This is an issue that
has troubled nearly all NTA analysis of
spent embryo culture media to date.
Instruments used for NTA can be fitted
with laser diodes capable of exciting
labelled extracellular vesicles that may
make distinguishing between the preexisting nanoparticle population much
easier (Dragovic et al., 2011). Of the four
published papers using flow cytometry,
two used aldehyde–sulfate latex beads
to first bind all extracellular vesicles and
bring these vesicles above the minimum
size threshold required for detection by
flow cytometry. Using flow cytometry,
two clinical studies analysed pooled
samples (Mellisho et al., 2017; Pallinger
et al., 2018). Saadeldin et al. (2014)
used group culture and Pallinger et al.
(2017) conducted a single study and
successfully analysed single blastocyst
media samples. Flow cytometry is an
expensive investment for an ART clinic;
however, media samples may be sent to
a local flow cytometry facility for analysis
in a matter of hours (Pallinger et al.,
2017). Both NTA and flow cytometry offer
accurate, rapid, single event resolution
with little to no processing of the initial
sample, avoiding both enrichment
bias and material loss, major factors
that would likely change substantially
from clinic to clinic. Specially tuned
flow cytometers, known as a nanoflow
cytometers, can resolve nanoparticles
as small as 40 nm, significantly lower
than the typical 200 nm cut-off for
conventional flow cytometers (Lian et al.,
2019). Nanoflow cytometry may resolve
smaller populations among media borne

extracellular vesicles, providing a more
comprehensive analysis of spent culture
media microdroplets conditioned with
single blastocysts. No publications using
nanoscale flow cytometry to this end
have yet been published.
Pre-existing nanoparticles in culture
media
Media-borne nanoparticles have been
reported within most culture media
before embryo exposure (Giacomini
et al., 2017; Pavani et al., 2019;
Vyas et al., 2019; Dissanayake et al.,
2020), likely originating from natural
media components such as human
or bovine serum albumin. Vyas et al.
(2019) reported pre-exposure media
concentration of nanoparticles 7.33 × 108
nanoparticles/ml, a value that dropped to
7.0 × 108 nanoparticles/ml after exposure,
suggesting embryo uptake of these
particles may have occurred (Vyas et al.,
2019). The population has been reported
to have extracellular vesicle character
(Giacomini et al., 2017) whereas, in
other studies, it did not (Pavani et al.,
2019; Dissanayake et al., 2020). A
pre-existing nanoparticle population
(6.65 × 1010 nanoparticles/ml) within the
media used by Pavani et al. (2019) was
not determined to have extracellular
vesicle character. Giacomini et al.
(2017) reported that blank human serum
albumin supplemented culture media
did not contain substantial particulate
numbers, and those that were present
did not exhibit extracellular vesicle
character; however, media supplemented
with serum substitute supplement
contained CD9+ / CD63+ extracellular
vesicles, ranging from 50–200 nm in
diameter with an average size of 70 nm
(Giacomini et al., 2017). In fact, in cases
in which a pre-existing nanoparticle
population was identified, it was orders of
magnitude greater than the net increase
contributed by the embryo during
culture (Vyas et al., 2019; Dissanayake
et al., 2020; Simon et al., 2020).
Extracellular vesicle and
preimplantation embryo
developmental competence
Embryo-derived exosomes are now
believed to serve as paracrine factors
and contribute to the ‘group culture’
effect, the observation that embryos of
all species experience higher blastocyst
rates after in-vitro culture when cultured
in groups (Lane and Gardner, 1992; Dai
et al., 2012). A significant increase in
developmental capacity was seen when

isolated vesicles were reintroduced
into the culture media of both murine
(Kim et al., 2019) and bovine zonaintact embryos (Qu et al., 2017; Pavani
et al., 2019). Studies have sought to link
extracellular embryonic extracellular
vesicles to developmental competence,
and data thus far have been promising.
Media conditioned with day-2 and day-8
bovine embryos that later degenerated
had significantly elevated extracellular
vesicles compared with those that
developed to the blastocyst stage
with normal morphology (8.3 × 108
versus 5.9 × 108 and 7.2 × 108 versus
5.7 × 108 nanoparticles/ml, respectively)
(Dissanayake et al., 2020). An initial
clinical pilot experiment by Abu-Halima
et al. (2017) suggested that significantly
lower extracellular vesicle concentrations
were present in media samples from
single blastocyst transfers that led to a
pregnancy compared with those that
did not (3.8 × 109 versus 7.35 × 109
nanoparticles/ml, respectively). A
subsequent study by Pallinger et al.
(2017) confirmed this result and
impressively revealed the predictive
power of a DNA-containing extracellular
vesicle subpopulation in correctly
forecasting clinical pregnancy outcome
after transfer of late-stage blastocysts that
had otherwise indistinguishable embryo
morphometrics (Pallinger et al., 2017).
This study, conducted using conventional
flow cytometry, was able to propose a
‘cut-off’ propidium iodide-positive (PI+)
extracellular vesicles concentration of
about 1 × 106 PI+ extracellular vesicles/
ml; implantation outcome could be
predicted with a sensitivity of 0.90 and a
specificity of 0.86 depending on whether
blastocyst conditioned media samples
had more or less than this number of PI+
extracellular vesicle in the microdroplet.
It is notable that Pallinger et al. (2017;
2018) successfully analysed crude
human and mouse blastocyst culture
media by traditional flow cytometry
without bead capture. The analysed
population was an annexin V+ and PI+
subpopulation, suggesting externalized
phosphatidylserine and DNA content,
characteristics traditionally associated
with an apoptotic subpopulation. This is
reinforced by results from Simon et al.
(2020) that showed about 16% of murine
blastocyst derived extracellular vesicles
contain DNA (Simon et al., 2020).
The connection between blastocyst
developmental competence and the
prevalence of extracellular vesicles in
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spent culture media has now been
established. Animal model studies
independently concluded degenerate
embryos release more extracellular
vesicles alongside independent
clinical claims connecting elevated
extracellular vesicles to implantation
failure. From a diagnostic perspective,
extracellular vesicles are meeting the
critical requirement that the extent
of extracellular vesicle release from
the blastocyst is more sensitive to its
developmental competence than to
any other uncontrollable variable, such
as mild deviations in its developmental
pace. Investigators have considerable
instrumentation at their disposal to
develop this connection further, including
targeting of exosomal, microvesicle
and apoptotic body subpopulations for
protein, DNA and RNA characterization.
We postulate artificial blastocyst cavity
rupturing will improve extracellular
vesicle detectability and invite the idea
that a natural, foreboding collapse may
even be the defining event that elevates
extracellular vesicles in the media of
compromised blastocysts. The avoidance
of sample freezing and additional
manipulation, such as zona pellucida
removal, may further amplify these trends.
MicroRNA
Of the diverse extracellular vesicle
cargo, encompassing major classes
of cellular molecular constituents,
including proteins, DNA and RNA
(Doyle and Wang, 2019), preference
towards a class of small RNA transcripts,
known as microRNA (miRNA), has
arisen in translational research owing
to their suitability as biomarkers as
a result of their enhanced stability
and rapid detectability (Kreth et al.,
2018). Extracellular miRNAs may
exist encapsulated within any class of
extracellular vesicles (Sohel, 2016),
with increasing evidence supporting
targeted packaging among the exosomal
fraction (Anand et al., 2019). miRNA
sequences are small (∼22 nt) non-coding
RNA sequences that serve to regulate
post-transcriptional gene expression
in animals, plants and viruses (Rana,
2007). Currently, an estimated 2300 true
human miRNA sequences exist (Alles
et al., 2019), many of which are highly
conserved across species, including
invertebrate model organisms (IbáñezVentoso et al., 2008). About one-half
of these sequences are expressed from
proximal genes, referred to as clusters,
and are predisposed to unified expression

(Kim and Nam, 2006). miRNAs are
processed to their mature form from
much lengthier precursor transcripts
and ultimately function by directing the
RNA-induced silencing complex to initiate
endonucleolytic cleavage of mRNA in a
process known as RNA silencing (Kim
et al., 2009). This complex comprises
numerous proteins and includes the
miRNA-primed endonuclease belonging
to the Argonaute (Ago) protein family
(Kim et al., 2009). Dependent only on
the nominal requirement of a tolerant
7 nt complementary base pair match
within the 3’ untranslated region of the
mRNA, a single miRNA sequence may
regulate hundreds of different mRNA
targets; it is believed as many as one-third
of human genes may be potential targets
for miRNA (Kim et al., 2009). A single
miRNA copy can initiate the cleavage
of many copies of each mRNA, further
underscoring the potency of this means
of transcriptional regulation. miRNAs
are transcribed ubiquitously across cell
types, including embryonic stem cells,
and in a cell- or tissue-specific manner
(The FANTOM Consortium et al., 2017);
in most cases, the top five miRNAs
account for about one-half of the total
miRNAs (The FANTOM Consortium
et al., 2017; O'Brien et al., 2018). The
extensive variety of miRNA expressed
in a given cell or tissue has empowered
comprehensive expression profiling, and
has led to the realization that miRNA
profiles may be significantly skewed as
a result of status changes, including
differentiation (Kulcenty et al., 2019)
or pathology (Peng and Croce, 2016).
Comprehensive miRNA profiling has
enabled the prioritization of previously
characterized cellular pathways based on
their enrichment with proteins prone to
transcriptional regulation according to
the current expression profile. miRNAs
are found extracellularly in many biofluids
(Weber et al., 2010) and the conditioned
culture media of many cell types,
including differentiating stem cells (Zhang
et al., 2016). It is most frequently bound
to Argonaute proteins (Turchinovich
et al., 2011), whereas encapsulation within
extracellular vesicles, such as exosomes,
microvesicles and apoptotic bodies, is less
common (Zhang et al., 2015). miRNAs
are detectable by polymerase chain
reaction (PCR), offering rapid and highly
sensitive detection in a matter of hours.
miRNAs are resistant to degradation after
days at room temperature (Mall et al.,
2013), after numerous freeze–thaw cycles
(Matias-Garcia et al., 2020) and even
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when total RNA integrity is compromised
(Jung et al., 2010). Together, these
attributes have led to intense investigation
of their utility as non-invasive diagnostic
biomarkers, spurring the detection
of cancer (Paranjape et al., 2009),
diabetes (Jiménez-Lucena et al., 2018),
cardiovascular disease (Zhou et al., 2018)
and other pathologies.
miRNAs in the preimplantation
embryo
The miRNA presence within the
preimplantation embryo represents
sequence contributions from the oocyte
and the spermatozoa, many of which
are actively degraded by the two-cell
stage (Tang et al., 2007), alongside
concomitant zygotic expression that
begins shortly after fertilization (Yang
et al., 2016) and steadily increases
towards the blastocyst stage (Byrne
and Warner, 2008; Yang et al., 2008;
Ohnishi et al., 2010; García-López
and del Mazo, 2012; Rosenbluth et al.,
2013; Berg and Pfeffer, 2017). By the
blastocyst stage, as many as 135 mature
miRNA sequences have confirmed
expression in the human, many of which
are embryonic-specific (Houbaviy et al.,
2003; Suh et al., 2004; Rosenbluth et al.,
2013) and span numerous predominant
clusters including: miR-15a/16-1, miR-1792, C19MC, miR-106a-363, miR-106b-25,
miR-302-367 and miR-371-373 (Houbaviy
et al., 2003; Svoboda and Flemr, 2010;
Battaglia et al., 2019). In fact, the miR290 cluster, homologues of the human
miR-371-373 cluster, account for more
than 60% of all miRNA sequences within
murine embryonic stem cells (Yuan et al.,
2017). miRNAs are highly conserved
between species with homologous
sequences and clusters bearing identical
seed sequences, validating the use of
animal model preimplantation embryos
as informative alternatives to the limited
human embryos available for research.
Multiple reports have already confirmed
distorted miRNA profiles within
blastocysts derived from donors with a
history of infertility (McCallie et al., 2010)
and those with differing chromosomal
status after PGT-A (Rosenbluth et al.,
2013). Indeed, even male and female
blastocysts likely have differentially
expressed miRNAs (Rosenbluth et al.,
2013).
miRNAs in the preimplantation
embryonic secretome
Extracellular miRNAs are now confirmed
within culture media microdroplets used
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to condition human, cow and mouse
embryos, as well as within the blastocyst
cavity of human preimplantation
embryos (TABLE 2). These reports will
be covered within this subsection with
focus on elements most relevant to
supporting diagnostic application. Major
revelations on the embryonic miRnome
will be detailed according to the binary
presence or absence of a particular
sequence, the total number of unique
mature sequences detected (referred
henceforth as the variety) and differences
in the concentration of each detectable
sequence between compared groups. In
all cases, only the mature forms of the
miRNA sequences are discussed and
no emphasis is placed on novel miRNA
sequences that have been most recently
proposed based on deep sequencing
experiments and are yet to be accepted
as bona-fide sequences.
Initial ‘miRnome’ studies did not detect
a miRNA signature in the media (KatzJaffe and McReynolds, 2013); however,
secretomic screening studies now
consistently report at least several
dozen detectable sequences, aided
by preamplification technology and
improved techniques. The miRnome
variety strongly overlaps with that of the
trophectoderm (Capalbo et al., 2016)
and likely represents the entire inner cell
mass and trophectoderm (Cimadomo
et al., 2019). The total variety of miRNAs
reported between studies has differed
according to the analytical depth of each,
i.e. from panels of single quantitative PCR
assays to next-generation sequencing).
The most strongly expressed blastocyst
miRNAs are most abundant in the culture
media and the blastocyst cavity, i.e. the
miR-371-373 cluster (Rosenbluth et al.,
2013; Battaglia et al., 2019; Cimadomo
et al., 2019). These sequences have
received the most attention, in addition
to sequences put forth by early clinical
reports that may correlate with ploidy
status or implantation outcome: miR20a (Capalbo et al., 2016), miR-30c
(Capalbo et al., 2016), miR-142-3p
(Borges Jr. et al., 2016) and miR-191
(Rosenbluth et al., 2014). Affirmatively,
whole bovine blastocysts with a history
of slow development underwent an
approximate 18-fold increase in miR-30c
and an approximate 30-fold increase
in miR-10b expression compared with
a faster cohort (Lin et al., 2019a). This
was accompanied by an approximate
13-fold increase in miR-30c and an
approximate 21-fold increase in miR-

10b within their respective conditioned
media microdroplets. As total miRNA
expression increases within the embryo
from the two-cell stage onwards (Tang
et al., 2007), greater amounts of miRNA
are found in the media: blastocysts
released much more miRNA than earlier
stages (Capalbo et al., 2016) and a
12-fold increase in miR-372 and 1.9-fold
increase in miR-191 were seen in day-5
versus day-4 ICSI-inseminated embryo
culture media samples (Rosenbluth
et al., 2014). Conditioning time is also
an important parameter, as media
collected when human embryos reached
the blastocyst stage on day 6/7 had
significantly more miRNA than from
faster developing blastocysts collected
on day 5 (Cimadomo et al., 2019). If
the media sampling occurred later on
day 6/7, a significantly greater variety of
miRNA panel members were detected
(6.7) compared with media collected on
day 5 (4.2).
Extracellular miRNA study design
Inter-study preimplantation miRnome
comparisons must be made cautiously
owing to the significant differences
in experimental designs and data
normalization. miRNA profiling depth
differed significantly and included panels
of quantitative reverse transcription PCR
and digital droplet PCR-based assays,
quantitative reverse transcription PCR
arrays and, most recently, NGS (TABLE 2).
The clinical studies interrogated media
conditioned with a single fresh embryo
either to the cleavage-stage on day 3
or to the blastocyst stage between days
5–7 before both biopsy and vitrification,
with the exception of a single study
that examined media conditioned with
embryos that had been cryopreserved
at the pronuclear stage (Rosenbluth
et al., 2014). Culture conditions varied
significantly across animal studies, i.e.
media selection, additives, microdroplet
sizes, embryo culture density and culture
times. In all studies, human and animal
models alike, data were presented as
either unnormalized (Gombos et al.,
2019), normalized to an exogeneous
spike-in (Kropp et al., 2014; Borges Jr.
et al., 2016; Abu-Halima et al., 2017;
Gross et al., 2017; Cimadomo et al.,
2019), normalized to an endogenous
control: snU6 (Rosenbluth et al., 2014;
Cuman et al., 2015; Heidari et al., 2019;
Lin et al., 2019a), B2M (Heidari et al.,
2019), SNORD96 (Sánchez-Ribas et al.,
2019), GAPDH (Kropp et al., 2014),
miR-16-2 (Abu-Halima et al., 2017) or

miR-372 (Battaglia et al., 2019), or a
combination of these strategies. The
choice of normalization strategy may
dictate the outcome of a secretomics
study (Abu-Halima et al., 2017). Data
normalization is a particularly troubling
issue with preimplantation embryo
secretomics studies for two reasons:
selection of suitable endogenous controls
is already an ongoing issue itself for
preimplantation embryos (Mamo et al.,
2007; Jeong et al., 2014; Mahdipour
et al., 2015); and such controls may no
longer be valid in an extracellular context
owing to the additional complexity added
by the release mechanism that may
violate their status as experimentally
insensitive variables. This may be
especially true if the ‘housekeeper’ is
located elsewhere than the cytosol, i.e.
nuclear, where mature miRNA resides
or, if the housekeeper is a separate
molecular class entirely such as an mRNA
or even protein. The appropriateness
of the chosen normalization strategy
is dependent on the importance of
the release mechanism in defining
the secretome, a truth that remains
unknown.
Extracellular miRNAs from nonembryonic sources
In line with extracellular vesicle
studies, an miRNA presence has been
continuously reported within commercial
conditioned media before embryo
exposure, possibly originating from a
number of sources, including natural
supplements added to commercial
media (Kropp et al., 2014; Rosenbluth
et al., 2014; Cuman et al., 2015;
Kropp and Khatib, 2015; Capalbo
et al., 2016; Sánchez-Ribas et al.,
2019). Persistent cumulus cells have
plagued interpretation of extracellular
genomic DNA collected during ongoing
development of niPGT and efforts to
retrieve mitochondrial DNA (Hammond
et al., 2017). Cumulus cells also express
miRNAs (Andrei et al., 2019), and it is
foreseeable these cells may be similarly
contributing to miRnome studies.
Even an NGS analysis of such media
has reported many extraembryonic
miRNA sequences (Sánchez-Ribas
et al., 2019). For clinical prospective
studies using donated embryos, it may
be worthwhile formulating media using
a synthetic human serum albumin
alternative to avoid the background that
has complicated many of the miRnome
studies (TABLE 2); similarly, animal research
studies may wish to culture in medium
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TABLE 2 STUDIES RESPONSIBLE FOR THE CURRENT KNOWLEDGE OF THE PREIMPLANTATION EMBRYO ‘MIRNOME’
Reference Species Culture media
purification
method

Detection
method

(SánchezRibas et al.,
2019)

Human

Centrifugation,
filtration, miRNeasy Kit

NGS, single
C
assays (2, qPCR
w/ PreAmp)

CM

53

miR-181b-5p and miR-191-5p were most commonly
detected; miR-191-5p was higher in euploid versus
aneuploid embryo media before normalization to
SNORD96; many miRNAs were also detected in
control media.

(Lin et al.,
2019a)

Bovine

miRNeasy Serum/ NGS, single as- B
Plasma Kit
says (5, qPCR)

CM

114

miR-30c and miR-10b elevated in slow versus intermediate cleaving embryos and their accompanying
microdroplets; miR-10b elevated in degenerate
versus blastocyst media.

(Heidari
et al., 2019)

Mouse

None

CM

3

Vitrified blastocysts showed reduced expression of
miR-16-1 and miR-let-7a compared with fresh blastocysts, whereas, conversely, let-7a, miR-16-1 and miR15a were upregulated in associated media samples
at both the blastocyst and outgrowth stages.

(Gombos
et al., 2019)

Human

miRNeasy Serum/ Single assay (1,
Plasma Kit
ddPCR

C

CM

1

miR-191-3p was the single sequence investigated;
sequence was significantly higher in competent
embryos than those leading to miscarriage.

(Cimadomo Human
et al., 2019)

miRCURY RNA
Isolation Kit

Array (qPCR
with PreAmp)

B

CM

29

Higher numbers of miRNAs from poor-quality CM;
association with developmental competence was
not determined.

(Battaglia
et al., 2019)

None

Array (qPCR
B
with PreAmp),
single assays (3,
ddPCR)

BF

89

miRNA sequences found in BF; miR-372 was notably more abundant than other miRs.

Human

Developmental Sample MicroRNAs Significance of study
stage
source identified,
n

Single assays (3, B
qPCR)

(Gross et al., Bovine
2017)

miRNeasy Serum/ FC (FireFly
Plasma Kit
Panel), single
assays (3,
qPCR)

B

CM

8

Eight miRNAs were differentially expressed between
male and female CM; all were significantly up-regulated in female media: miR-15b, miR-16, miR-16-2,
miR-17, miR-22, miR-30b, miR-122, miR-320a.

(Abu-Halima Human
et al., 2017)

miRNeasy Micro
Kit

Microarray,
single assays
(qPCR)

B

CM

621

A total of 102 miRNA sequences were significantly
different between pregnancy versus non-pregnancy
groups with miR-29c-3p being the most different;
miR-634 and miR-30c were highly expressed CM
sequences; competent embryos have less miRNA
variety in CM; 101 miRNAs overlapped with those
found within spermatozoa.

(Capalbo
et al., 2016)

Human

BC

Array (qPCR)

C, M, B

CM, TE

59

Blastocysts released the greatest amount of miRNA;
57 secretome sequences overlapped with those in
the TE.

(Borges Jr.
et al., 2016)

Human

None

Single assays (7, C
qPCR)

CM

4

miR-142-3p was significantly more expressed in CM
from non-implantation versus implantation groups.

CM

11

Media conditioned with degenerate embryos had
higher concentrations of miRNAs; many miRNAs in
control media were absent in CM.

(Kropp and Bovine
Khatib, 2015)

miRNeasy Serum/ miRNA-seq
Plasma Kit

(Cuman
et al., 2015)

Human

miRCURY RNA
Biofluids Isolation
Kit

qPCR array,
B
single assays (1,
qPCR)

CM

47

A total of 19 sequences were exclusive to the
implanted group, whereas 22 were exclusive to
the non-implanted group; miR-661 was the highest
differentially expressed sequence; 22 miRNAs were
only present in control media.

(Rosenbluth
et al., 2014)

Human

None

qPCR array

B

CM

10

miR-191-5p was 3.7-fold higher in CM conditioned
with aneuploid versus euploid embryos.

miRNeasy Serum/ Single assays (6, B
Plasma Kit
qPCR)

CM

1

miR-25 was detected in CM; miR-196a2 in control
CM miRNAs was decreased after embryo exposure.

(Kropp et al., Human,
2014)
Bovine

B, E

B, blastocyst; BC, bead capture; BF, blastocyst fluid; C, cleavage-stage; CM, culture media; ddPCR, digital droplet polymerase chain reaction; E, expanded blastocyst;
FC, flow cytometry; M, morula; NGS, next-generation sequencing; qPCR, quantitative polymerase chain reaction; TE, trophectoderm.

free of bovine serum albumin or in
medium supplemented with a synthetic
macromolecular alternative, such as
polyvinylpyrrolidone (Pavani et al.,
2019) or polyvinyl alcohol (Biggers,
1997). Spermatozoa are also carriers of
mature miRs, some of which are critical

for the initiation of preimplantation
development (Liu et al., 2012), and it
is conceivable that unsuccessful zonabound spermatozoa may contribute
to the secretome in non-ICSI studies,
such as those reliant on IVF or animal
studies using naturally fertilized oocytes.

Rosenbluth et al. (2014) reported a
lack of correlation with pregnancy
outcome for ICSI-inseminated embryos
that otherwise held for those regularly
inseminated (Rosenbluth et al., 2014). It
is, however, difficult to conclude whether
this difference is attributable to accessory
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spermatozoa or instead due to the
physically damaging ICSI procedure itself
causing leakage into the media; the two
significant correlative miRNAs identified
within this study, miR-191 and miR-372,
were both elevated in ICSI versus nonICSI blastocyst culture media.
Exogeneous miRNA uptake
The existence of miRNAs before the
arrival of the embryo has not been
completely detrimental, however, as it
has led investigators to consider that
embryos may also be taking up miRNAs.
Pre-existing preimplantation embryonic
miRNA levels drop within the media
after exposure in a handful of studies
(Kropp et al., 2014; Rosenbluth et al.,
2014; Kropp and Khatib, 2015; Lin et al.,
2019b), much like purported extracellular
vesicle uptake (Saadeldin et al., 2014;
Vyas et al., 2019). Cuman et al. (2015)
reported a population of 22 control
exclusive miRNAs when comparing
controls with blastocyst conditioned
media (Cuman et al., 2015). Kropp et al.
reported miR-196a2 was detected at
significantly reduced amounts in culture
media after bovine blastocyst culture
compared with controls (Kropp et al.,
2014). In a follow-up study, Kropp and
Khatib (2015) reported that eight preexisting miRNAs were downregulated
in groups with blastocysts compared
with only two in groups with degenerate
embryos (Kropp and Khatib, 2015).
Rosenbluth et al. (2014) reported that
a single pre-existing sequence, miR645, was downregulated to a greater
extent in media exposed to embryos
with confirmed implantation success
than those that failed; in fact, a six-fold
increase in this sequence was associated
with implantation failure for non-ICSI
blastocysts (Rosenbluth et al., 2014). It is
possible that healthier embryos absorb
more miRNA. miRNA uptake could, in
part, be due to the miRNAs existing in
an encapsulated state; however, studies
introducing unprotected exogeneous
miRNAs into the culture media of bovine
preimplantation embryos (Kropp and
Khatib, 2015; Lin et al., 2019a; 2019b)
and trophoblast cell lines (Cuman
et al., 2015) have also reported uptake.
Neither miR-30c or miR-10b media
supplementation affected bovine
blastocyst development from the zygote
stage (Lin et al., 2019a; 2019b), whereas
miR-24 supplementation significantly
reduced blastocyst development from
75.6% to 48.3% when introduced at the
morula-stage (Kropp and Khatib, 2015).

Unravelling the mechanism of miRNA
release has been approached using
trophoblast cell lines and has received
little attention from studies using whole
embryos that instead have focused on
correlating miRNA profiles with embryo
quality. Cuman et al. (2015) used a
trophoblast cell line to condition media
and characterized the presence of miR661 (a sequence identified previously
within this study from a media study using
whole human preimplantation embryos).
The results showed that most miR-661
was protein-bound to Ago2, with the
balance likely being encapsulated. This
conclusion agrees with the observation
that two sequences of interest (miR-181b5p and miR-191-5p) were present within a
high molecular weight protein fraction of
the embryo conditioned media (SánchezRibas et al., 2019).
miRNA presence in the blastocyst
cavity
miRNA profiling of the human blastocyst
cavity fluid identified 89 miRNA
sequences after sampling nine human
blastocysts, representative of most of the
known miRNA clusters expressed at this
stage (Battaglia et al., 2019). Among the
most prevalent miRNAs, miR-372 of the
miR-371-373 cluster is a sequence with
similarly high expression at the blastocyst
stage (Rosenbluth et al., 2013) and is
regarded as one of the most prevalent
miRNAs comprising the extracellular
secretome (Rosenbluth et al., 2014;
Cimadomo et al., 2019). Similar high
expression of the homologous miR290-295 cluster is seen in later stages
of preimplantation development in
numerous model organisms (Yang
et al., 2008; Maraghechi et al., 2013).
Battaglia et al. (2019) recognized that
80% of these sequences were previously
categorized as ‘exo-miRs’ (sequences with
a predisposition for exosomal packaging)
and 40 overlapped with those observed
in spent blastocyst media previously
(Capalbo et al., 2016). When considered
along with the observation of exosomes
and other extracellular vesicles within
the blastocyst cavity of multiple species,
the possibility for these sequences
to be encapsulated warrants further
investigation.
Extracellular miRNAs and
preimplantation embryo
developmental competence
Clinical studies have sought to correlate
the miRnome with pregnancy outcomes
after transfer and association with ploidy

status according to PGT-A data, whereas
studies involving animal models have
sought correlation with morphology,
developmental pace, ability to form
outgrowths (Heidari et al., 2019)
and cryopreservation (TABLE 2). Ailing
blastocysts presenting degenerating
morphology confirmed that implantation
failure or even a history of vitrification
release greater amounts and variety of
miRNA sequences into the spent culture
medium; however, the correlation with
ploidy status remains unclear. miR-16-1
and let-7a, despite being downregulated
in whole vitrified murine blastocysts
compared with fresh blastocyst controls
(∼5-fold and ∼1.5-fold, respectively),
showed an increase in the concentration
of both sequences (∼16-fold each)
in the conditioned medium (Heidari
et al., 2019). Given the transcriptional
overlap between the secretome and
the trophectoderm and even whole
embryo, this may suggest that vitrified
embryos have a much more active
release mechanism, i.e. apoptosis, and
that other sequences may have been
similarly elevated. Comparing euploid
and aneuploid blastocyst conditioned
media, Rosenbluth et al. (2014) detected
a 4.7-fold increase in miR-191-5p within
the aneuploid media; however, SánchezRibas et al. (2019) did not detect any
significant differences.
Abu-Halima et al. (2017) used
implantation success as the metric
of developmental competence, and
reported that media samples from
blastocysts leading to implantation failure
had an average of 163 different miRNAs,
whereas those that led to pregnancy had
149 (Abu-Halima et al., 2017). Cuman
et al. (2015) observed a 19-miRNA
exclusive subset within media of day5 blastocysts that led to an ongoing
pregnancy and a 22-miRNA exclusive
subset within the non-implanted group. A
single, highly expressed miRNA sequence
(miR-661) was repeatedly expressed
exclusively and at significant levels in the
media of five non-implanted, individually
cultured blastocysts. Furthermore, miR372 was only observed within media of
embryos that failed to implant (Cuman
et al., 2015). Rosenbluth et al. (2014)
reported a significant increase in U6
normalized miR-191-5p expression in
media of aneuploid embryos compared
with those that were euploid (Rosenbluth
et al., 2014); additionally, a 7.1-fold
increase in miR-372 and a 5.1-fold
increase in miR-191-5p were seen in
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FIGURE 1 Current view of the extracellular vesicle and microRNA (miRNA) contributions to the human preimplantation embryo secretome

(conceptual, not to scale). (A) Trends in the secretomic extracellular vesicles and miRNA presence throughout preimplantation development and
their known association with developmental competence; (I) preimplantation embryos release extracellular vesicles at all stages of development;
(II) culture media extracellular vesicles and miR-372 are increasing towards the blastocyst stage; (III) competent embryos release fewer extracellular
vesicles and fewer miR-371-373 sequences; (B) known presence of extracellular vesicles and miRNAs within the blastocyst cavity, perivitelline
space, zona pellucida and secretome, including possible major release mechanisms; (I) blastocyst-conditioned media contains extracellular vesicles
positive for tetraspanins CD9 and CD63, in addition to a secondary, larger vesicle population that may be microvesicles or apoptotic bodies.
Competence-associated miR-191 and miR-371-373 sequences are prevalent and miR-191 is believed to be bound to a >100 kDa protein, possibly to
Argonaute; (II) exosomes have bidirectional movement across the zona pellucid; (III) natural breakdown of trophectoderm and rupture of blastocyst
cavity may release contents into perivitelline space and eventually culture media; (IV) CD9+ vesicles are present within the perivitelline space;
(V) breach of the zona pellucida during blastocyst hatching may be responsible for the observation of media extracellular vesicles >200 nm in
diameter; (VI) possible exosome release from fused multivesicular bodies based on their confirmed presence within the murine trophectoderm;
(VII) blastocyst cavity contains exosomes that are CD63+ and CD81+, in addition to prevalent miRNA sequences from the miR-371-373 cluster. The
presence of multiple tetraspanins per vesicle is possible and not depicted. AGO, Argonaute protein; PS, phosphatidyl serine.

media from failed non-ICSI blastocyst
transfers compared with those that
led to a pregnancy (Rosenbluth et al.,
2014). The link between developmental
competence and miR-191-5p is agreed
upon; in contrast, direct counting of
miR-191-5p without normalization to an
endogeneous housekeeper was shown
to be significantly higher in media from
euploid versus aneuploid embryos
(Sánchez-Ribas et al., 2019). A study
dedicated to resolving miR-191-3p
media expression (the complementary
mature sequence to miR-191-5p)
reported an approximate 10-fold higher
non-normalized expression in media
of competent blastocysts leading to a
live birth (Gombos et al., 2019). Three
other sequences displayed a significantly
different detection rate (present versus
not present) between not pregnant
versus pregnant: miR-182-5p, miR-3023p, miR-519d-3p; in all cases, these
sequences were more often found in
media from non-pregnant embryos
(Cimadomo et al., 2019). In this study,

each of the 10-sequence panel of miRNA
sequences were more abundant in the
non-pregnant media and four reached
significance: miR-302a-3p, miR-372-3p,
miR-373-3p, miR-518a-3p; however, none
of these were significant after accounting
for the confounding variable that the
non-pregnancy media group contained
more day 6/7 blastocyst samples than day
5 samples. The increased conditioning
time required for the blastocysts of
the non-pregnant group may be the
reason for this. Contrary to this study,
miR-20a and miR-30c were both higher
in media of euploid implanted versus
non-implanted blastocysts (Capalbo
et al., 2016). Comparison of media
from poor-quality euploid blastocysts
with confirmed implantation failure with
that conditioned with day-matched
controls, the mean average number of
miRNAs detected on a 10-miR panel was
significantly higher (8.5 versus 6.7) in
the poor-quality media. Additionally, the
media from these substandard embryos
contained a significantly elevated amount

of miR-373-3p than the day-matched
blastocyst control media (Cimadomo
et al., 2019).
In an attempt to establish a correlation
with morphometrics, Lin et al. (2019)
probed media conditioned with either
slow-cleaving, degenerate-containing
bovine embryo cohorts or more
moderately paced groups of embryos
with less degenerate embryos for select
sequences (Lin et al., 2019a). Medium
conditioned with degenerate embryos
had a nearly three-fold increase in miR10b and a 30-fold increase in miR-30c
compared with medium conditioned
by healthy looking blastocysts.
Kropp and Khatib (2015) conducted
miRNA-sequencing analysis on media
conditioned with bovine embryos from
the morula to blastocyst stage and
pooled according to whether normal or
degenerative development occurred.
Three miRNA sequences showed
significant differential expression, each
of which were higher in the degenerate
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media: miR-24, miR-191 and miR-148a.
miRNAs are undoubtedly present in
the spent embryo conditioned media.
It is also clear that embryos of different
status, including sex (Rosenbluth et al.,
2013; Gross et al., 2017), have different
intrinsic and extracellular miRNA
profiles, a promising first step towards
their use as biomarkers. The blastocyst
cavity is an equally viable source of
miRNA and is also enriched for highly
expressed blastocyst sequences. While
undesirable, the presence of pre-existing
miRNAs within commercial media
may not pose a significant obstacle to
embryo diagnostics given the availability
of embryo-specific miRNAs transcribed
and released by the blastocyst. Embryos
exhibiting degeneracy or with a history
of vitrification are releasing a greater
variety and amounts of miRNAs into
the culture media. Differences in
miRNA release between euploid and
aneuploid embryos exist, yet a decisive
correlation has yet to be found.
Despite overlap in some differentially
expressed media sequences between
studies, no individual sequences have
yet been repeatedly identified across
multiple independent studies that
hold adequate predictive power to
forecast a single blastocyst transfer
outcome. Currently, the abundant
miR-371-373 cluster and miR-191 are
the most promising prospects for
such a correlation with developmental
competence. Maintenance of consistent
culture conditions between embryos
both intra- and interstudy are critical
owing to the effect of conditioning
time on the miRnome. Variability in
embryo developmental pace and the
rapidly increasing miRNA production
as development moves towards the
blastocyst stage are other variables that
must be managed, along with additional
factors such as fertilization method and
cryopreservation that seem to be having
an effect. Moving forward, it would
be beneficial to establish a common
normalization strategy for extracellular
sequences and supplement datasets with
non-standardized data until the release
mechanisms are better understood.
In conclusion, extracellular vesicles
are proving to be a robust metric
of embryonic health. Multi-study
agreement exists that embryos exhibiting
degeneracy and with confirmed
implantation failure are shedding greater
numbers of vesicles into the culture
media. The potential for developing a

diagnostic tool based on an assessment
of the blastocyst's extracellular vesicle
secretome is especially promising, as
subpopulations bearing distinct markers
and cargo are only just being explored.
The picture is not yet so clear for
microRNA. MicroRNA studies have
been faced with the arguably greater
challenge of reliably snapshotting a
complex network of regulators that
are being actively transcribed with
ongoing development. Although some
correlation between the amplitude
of the miRnome with aneuploidy
and degeneracy is agreed upon, the
miRnome currently seems equally
or more sensitive to environmental
variables. The primacy of ending culture
when a fully developed blastocyst is
ready for transfer is an example of an
uncontrollable environmental variable
that seems capable of impeding reliable
miRnome profiling. A lack of consensus
about the appropriate control variables
further clouds interstudy comparison.
The sheltered blastocyst cavity may
prove to be a solution to some of these
issues. The currently conflicting results,
particularly regarding miR-191, may
shift to overwhelming agreement once
the most clinic-specific environmental
variables are better understood and
controlled.
FIG 1.
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